ScholarLens Back to search
2006•Journal of clinical and experimental medicineRequires access

Transurethral plasmakinetic vaporization of prostate for treatment of benign prostate hyperplasia

Jing Xia-yon

Open publisher page 0 citations

Abstract

Objective To assess the safety and efficacy of transurethral plasmakinetic vaporization of prostate(TUPKVP).Methods Thirty-six 36patinets(means age of 72.5 years,range from 64to 87)with symptomatic BPH were treated by TUPKVP.Results All patients were followed to of 3-6 month postoperatively.The peak flow rate increased from(7.5±2.0)ml/s to(14.2±3.1)ml/s;The IPSS decreased from(26.5±5.5) to(16.3±4.5),Residual urine volume decreased from(130±40)ml to(15.5±5.5)ml.Conclusion It is suggested that TUPKVP is effective,high safety and less complications.

About this research paper

What this paper is about

Objective To assess the safety and efficacy of transurethral plasmakinetic vaporization of prostate(TUPKVP).Methods Thirty-six 36patinets(means age of 72.5 years,range from 64to 87)with symptomatic BPH were treated by TUPKVP.Results All patients were followed to of 3-6 month postoperatively.The peak flow rate increased from(7.5±2.0)ml/s to(14.2±3.1)ml/s;The IPSS decreased from(26.5±5.5) to(16.3±4.5),Residual urine volume decreased from(130±40)ml to(15.5±5.5)ml.Conclusion It is suggested that TUPKVP is effective,high safety and less complications.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To assess the safety and efficacy of transurethral plasmakinetic vaporization of prostate(TUPKVP).Methods Thirty-six 36patinets(means age of 72.5 years,range from 64to 87)with symptomatic BPH were treated by TUPKVP.Results All patients were followed to of 3-6 month postoperatively.The peak flow rate increased from(7.5±2.0)ml/s to(14.2±3.1)ml/s;The IPSS decreased from(26.5±5.5) to(16.3±4.5),Residual urine volume decreased from(130±40)ml to(15.5±5.5)ml.Conclusion It is suggested that TUPKVP is effective,high safety and less complications.

Key concepts: Medicine, Urology, Prostate, Hyperplasia, Vaporization, Urine flow rate, Urine, Residual urine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Transurethral plasmakinetic vaporization of prostate for treatment of benign prostate hyperplasia — Research Paper | ScholarLens